Tuesday, November 29, 2022

Partner Profiles

Defence's successful study on the ACCUVAC-PT007 vaccine

Defence’s successful study on the ACCUVAC-PT007 vaccine

Defence Therapeutics Inc. has announced its successful study on its ACCUVAC-PT007 vaccine, which targets cervical cancer. Defence Therapeutics Inc. a Canadian biopharmaceutical company specialised in...
LumiraDx continue rapid microfluidic immunoassay HbA1c test expansion

LumiraDx continue rapid microfluidic immunoassay HbA1c test expansion

LumiraDx's rapid microfluidic immunoassay HbA1c test will now be available in Europe, parts of the Middle East, Asia, Latin America, and Africa. Early customers...
Luxembourg government approve Azenta MoU on cold chain solutions

Luxembourg government approve Azenta MoU on cold chain solutions

Azenta, Inc. and the Government of Luxembourg today announced the signing of a Memorandum of Understanding (MoU) to facilitate continued healthcare technology and the...


Pin It on Pinterest